ConforMIS announced results from several clinical research studies highlighting the benefits of the iTotal customized total knee replacement.
The results were shown at the British Association for Surgery of the Knee meeting in Norwich, UK.
The results presented include the following:
• A study found that in a population of 89 patients and 106 knees treated, no patients required blood transfusions and mean preoperative range of motion was regained within an average of four months.
• A study found that in a population of 63 patients treated with iTotal, 100 percent achieved alignment within ± 2 of the neutral mechanical axis.
• Finally, a study found that use of iTotal significantly improves tibial fit when compared to off-the-shelf total knee replacement implants.
ConforMIS is a medical device company focusing on patient-specific orthopedic implants.
More Articles on Devices:
Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws